Trial intelligence / Profile preview

PETN for endothelial dysfunction in stable coronary artery disease

ISRCTN14741769Phase 4Completed

Sponsor
Johannes Gutenberg University Mainz
Start
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Pentaerythrityl tetranitrate with Placebo (2 arms). Primary endpoint: Flow-mediated dilation. Started Jun 2007; status: completed.

02

Drugs

pentaerythrityl tetranitrate
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ISRCTN14741769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN14741769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call